In Vivo Dosimetry During Prostate Cancer Radiotherapy

Completed · Phase 1

Conditions studied: Prostate Disease

In brief

The goal of this clinical research study is to learn if a rectal balloon with attached radiation detectors can be used to help researchers monitor the dose of external beam radiation that is delivered to the prostate during treatment. This may help researchers better understand the side effects of radiation therapy, such as rectal bleeding, and may lead to changes in treatment planning or treatment delivery.

Key facts

Study ID

NCT01307852

Run by

M.D. Anderson Cancer Center

People needed

7

Starts

2011-11-01

Expected to finish

2015-09-01

Last updated by the study team

2016-04-06

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Any patients with prostate cancer who are undergoing routine radiation therapy for their prostate cancer, including post-prostatectomy patients.
• The selection criteria will be limited to the patient's ability to withstand insertion of a rectal balloon and his willingness to participate in the study.
• We will choose patients undergoing photon and proton treatments.

You may not qualify if…

• N/A

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.